Combination antifungal therapy
- 1 June 2003
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 22 (6) , 555-556
- https://doi.org/10.1097/01.inf.0000070843.65157.31
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Comparison of Caspofungin and Amphotericin B for Invasive CandidiasisNew England Journal of Medicine, 2002
- In Vitro Activities of Ravuconazole and Voriconazole Compared with Those of Four Approved Systemic Antifungal Agents against 6,970 Clinical Isolates of Candida sppAntimicrobial Agents and Chemotherapy, 2002
- In Vitro Activities of Terbinafine in Combination with Fluconazole, Itraconazole, Voriconazole, and Posaconazole against Clinical Isolates of Candida glabrata with Decreased Susceptibility to AzolesJournal of Clinical Microbiology, 2002
- Aspergillosis Case-Fatality Rate: Systematic Review of the LiteratureClinical Infectious Diseases, 2001
- Invasive Aspergillosis Disease Spectrum, Treatment Practices, and OutcomesMedicine, 2000
- Practice Guidelines for Diseases Caused by AspergillusClinical Infectious Diseases, 2000
- Practice Guidelines for the Management of Cryptococcal DiseaseClinical Infectious Diseases, 2000
- Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency SyndromeNew England Journal of Medicine, 1997
- Combination Therapy in Experimental Invasive AspergillosisThe Journal of Infectious Diseases, 1993
- The Effect of Ketoconazole on Amphotericin B in a Model of Disseminated AspergillosisThe Journal of Infectious Diseases, 1985